However, it is presently unclear as why Alzheimer's, Type II Diabetes, Long-term potentiation and Neurotrophin signaling pathways genes are up-regulated in SCLC-COID groups since their roles in cancer are not well founded. This evidence concerns the gene BDNF and small cell lung carcinoma.